Biology of Oxidative Stress

  • Irène Ceballos-Picot
Part of the Neuroscience Intelligence Unit book series (NIU.LANDES)

Abstract

The element oxygen (O) exists in air as a molecule (O2) known as dioxygen or molecular oxygen. It was first isolated and characterized between 1772–1774 by the individual skills of the great European scientists Lavoisier and Scheele. Dioxygen, hereafter referred to as oxygen, appeared in significant amounts on the surface of the Earth some 2.5 × 109 years ago, and geological evidence suggests that this was due to the photosynthetic activity of micro-organisms (blue-green algae). The slow and steady rise in atmospheric oxygen concentration was accompanied by the formation of the ozone layer in the stratosphere. Both oxygen and the ozone layer acted as critical filters against the intense solar ultraviolet light reaching the surface of the Earth. The universe exists predominantly as hydrogen (H) and helium (He) with the Earth as a unique center of oxidation in an otherwise reducing universe.

Keywords

Dopamine Lipase Neurol Bilirubin Thiol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hirano A. Cytopathology of amyotrophic lateral sclerosis. Adv Neurol 1991; 56: 91–101.PubMedGoogle Scholar
  2. 2.
    Trojanowski J, Schmidt M et al. Altered tau and neurofilament proteins in neurodegenerative diseases: Diagnostic implications for Alzheimer’s disease and Lewy body dementias. Brain Pathol 1993; 3: 45–54.PubMedGoogle Scholar
  3. 3.
    Goldman JE, Yen SH. Cytoskeletal protein abnormalities in neurodegenerative diseases. Ann Neurol 1986; 19: 209–223.PubMedGoogle Scholar
  4. 4.
    Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 2nd edn, Oxford University Press, Oxford, 1989.Google Scholar
  5. 5.
    McCord JM, Fridovich I. Superoxide dismutase an enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6059–6055.Google Scholar
  6. 6.
    Moncada S, Higgs EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 1991; 21: 361–374.PubMedGoogle Scholar
  7. 7.
    Beckman JS, Beckman TW, Chen J et al. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620–1624.PubMedGoogle Scholar
  8. 8.
    Fenton HJH. Oxidation of tartaric acid in the presence of iron. J Chem Soc (Lond) 1894; 65: 899–903.Google Scholar
  9. 9.
    Halliwell B. Reactive oxygen species in living systems: source, biochemistry and role in human disease. Am J Med 1991; 91: 14–21.Google Scholar
  10. 10.
    Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47: 412–427.PubMedGoogle Scholar
  11. 11.
    Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. Biochem J 1973; 134: 707–16.PubMedGoogle Scholar
  12. 12.
    Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 1980; 191: 421–27.PubMedGoogle Scholar
  13. 13.
    Evans PH. Free radicals in brain metabolism and pathology. British Medical Bull 1993; 49: 577–587.Google Scholar
  14. 14.
    Reiter JR. Oxidative processes and anti-oxidative defense mechanisms in the aging brain. FASEB J 1995; 9: 526–533.PubMedGoogle Scholar
  15. 15.
    Ceballos I, Javoy-Agid F, Delacourte A et al. Parkinson’s disease and Alzheimer’s disease: neurodegenerative disorders due to brain antioxidant system deficiency? In: Emerit et al, eds. Antioxidants in Therapy and Preventive Medicine, Plenum Press: New York, 1990: 493–498.Google Scholar
  16. 16.
    Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609–1623.PubMedGoogle Scholar
  17. 17.
    Sokoloff L. The metabolism of the central nervous system in vivo. In: Field J, Magoun HW, Hall VE, eds. Handbook of Physiology-Neurophysiology American Physiological Society, Washington, DC, 1960; 3: 1843–1864.Google Scholar
  18. 18.
    Rice-Evans C, Burdon R. Free radical-lipid interactions and their pathological consequences. Prog Lipid Res 1993; 32: 71–110.PubMedGoogle Scholar
  19. 19.
    Harman D, Hendricks S, Eddy DE et al. Prolongation of life: role of free radical reactions in aging. J Am Geriatr Soc 1976; 17: 721–725.Google Scholar
  20. 20.
    Sadrzadek SMH, Eaton JW. Hemoglobin related oxidant damage to the central nervous system requires exogenous ascorbate. J Clin Invest 1988; 82: 1510–1516.Google Scholar
  21. 21.
    Sadrzadek SM, Anderson DK, Porter SS et al. Hemoglobin potentiates central nervous system damage. J Clin Invest 1987; 79: 662–664.Google Scholar
  22. 22.
    Dugan LL, Choi DW. Excitotoxicity, free radicals, and cell membrane changes. Ann Neurol 1994; 35: 517–521.Google Scholar
  23. 23.
    Choi DW. Excitotoxic cell death. J Neurobiol 1992; 23: 1261–1276.PubMedGoogle Scholar
  24. 24.
    Dawson VL, Dawson TM, London ED et al. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 1991; 88: 6368–6371.PubMedGoogle Scholar
  25. 25.
    McCord J, Ormar BA. Sources of free radicals. Toxicol Indust Health 1993; 9: 23–37.Google Scholar
  26. 26.
    Winterbourn CC. Comparison of superoxide with other reducing agents in the biological production of hydroxyl radicals. Biochem J 1979; 182: 625–628.PubMedGoogle Scholar
  27. 27.
    Spina MB, Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson’s disease. Proc Natl Acad Sci USA 1989; 86: 1398–1400.PubMedGoogle Scholar
  28. 28.
    Graham DG. Oxidative pathways for catecholamines in the genesis of neuro-melanin and cytotoxic quinones. Molec Pharmac 1978; 14: 633–643.Google Scholar
  29. 29.
    Colton CA, Gilbert DL. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987; 223: 284–288.PubMedGoogle Scholar
  30. 30.
    Lafon-Cazal M, Pietri S, Culcasi M et al. NMDA-dependent superoxide production and neurotoxicity. Nature 1993; 364: 535–537.PubMedGoogle Scholar
  31. 31.
    Glenner GG. Alzheimer’s disease: its proteins and genes. Cell 1988; 52: 307–308.PubMedGoogle Scholar
  32. 32.
    Loo DT, Copani A, Pike CJ et al. Apoptosis is induced by f3-amyloid in cultured nervous system neurons. Proc Natl Acad Sci USA 1993; 90: 7951–7955.PubMedGoogle Scholar
  33. 33.
    Behl C, Davis JB, Lesley R et al. Hydrogen peroxide mediates amyloid 13 protein toxicity. Cell 1994; 77: 817–827.PubMedGoogle Scholar
  34. 34.
    Thery C, Chamak B, Mallat M. Cytotoxic effect of brain macrophages on developing neurons. Eur J Neurosci 1991; 3: 1155–1164.PubMedGoogle Scholar
  35. 35.
    Jaffrey SR, Snyder SH. Nitric oxide: a neural messenger. Annu Rev Cell Dev Biol 1995; 11: 417–440.PubMedGoogle Scholar
  36. 36.
    Itzhak Y, Ali SF. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 1996; 67: 1770–1773.PubMedGoogle Scholar
  37. 37.
    Dawson VL, Kizushi VM, Huang PL et al. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase deficient mice. J Neuroscience 1996; 16: 2479–2482.Google Scholar
  38. 38.
    Hantraye P, Brouillet E, Ferrante R et al. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Med 1996; 2: 1017–1021.PubMedGoogle Scholar
  39. 39.
    Schultz JB, Matthews RT, Muqit MMR et al. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 1995; 64: 936–939.Google Scholar
  40. 40.
    Przedborski S, Jackson-Lewis V, Yokoyama R et al. Role of nitric oxide in MPTP-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 1996; 93: 4565–4571.PubMedGoogle Scholar
  41. 41.
    Ischiropoulos H, Chen J, Tsai HM et al. Peroxynitrite (ONOO-) reacts with superoxide dismutase to give the reactive nitronium ion. Free Rad Biol Med 1990; 9 (Suppl.l): 131.Google Scholar
  42. 42.
    Ischiropoulos H, Zhu L, Chen J et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992a; 298: 431–437.PubMedGoogle Scholar
  43. 43.
    Beckman JS, Ischiropoulos H, Zhu L et al. Kinetics of superoxide dismutase and iron catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys 1992; 298: 438–445.PubMedGoogle Scholar
  44. 44.
    Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992; 32: 297–311.PubMedGoogle Scholar
  45. 45.
    Garthwaite J. Nitric oxide signaling in the nervous system. Semin Neurosci 1993; 5: 171–80.Google Scholar
  46. 46.
    Shuman EM, Madison DV. The intercellular messenger nitric oxide is required for long-term potentiation. Science 1991; 254: 1503–6.Google Scholar
  47. 47.
    Shibuki K, Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 1991; 349: 326–8.PubMedGoogle Scholar
  48. 48.
    Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768–70.PubMedGoogle Scholar
  49. 49.
    Karanth S, Lyson K, McCann SM. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 1993; 90: 3383–7.PubMedGoogle Scholar
  50. 50.
    Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336: 385–8.PubMedGoogle Scholar
  51. 51.
    Knowles RG, Palacios M, Palmer RMJ et al. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 1989; 86: 5159–62.PubMedGoogle Scholar
  52. 52.
    Huang Z et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994; 265: 1883–1885.PubMedGoogle Scholar
  53. 53.
    Lipton SA et al. A redox-based mechanism in the neuroprotective and neurodestructive effect of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626–632.PubMedGoogle Scholar
  54. 54.
    Zhang J, Dawson VL, Dawson TM and Snyder SH. Nitric oxide activation of polyADP-ribose synthetase in neurotoxicity. Science, 1994; 263: 687–690.PubMedGoogle Scholar
  55. 55.
    Bolanos JP, Simon JR, Heales SJR, Land JM, Clark JB. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J Neurochem 1995; 64: 1965–1972.PubMedGoogle Scholar
  56. 56.
    Brown GC. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 1995; 369: 136–139.PubMedGoogle Scholar
  57. 57.
    Solodkin A, Traub RJ, Gebhart GF. Unilateral hindpaw inflammation produces a bilateral increase in NADPH-diaphorase hisotchemical staining in the rat lumbar spinal cord. Neuroscience 1992; 51: 495–499.PubMedGoogle Scholar
  58. 58.
    Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–142.PubMedGoogle Scholar
  59. 59.
    Boje KM, Arora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992; 587: 250–256.PubMedGoogle Scholar
  60. 60.
    Murphy S, Minor RL Jr, Wel G et al. Evidence for an astrocyte-derived vasorelaxing factor with properties similar to nitric oxide. J Neurochem 1990; 55: 349–351.PubMedGoogle Scholar
  61. 61.
    Galea E, Feinstein D, Reis D. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci USA 1992; 89: 10945–10949.PubMedGoogle Scholar
  62. 62.
    Nakane M, Schmidt H, Pollock J et al. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993; 316: 175–180.PubMedGoogle Scholar
  63. 63.
    Ignarro U. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991; 41: 485–90.PubMedGoogle Scholar
  64. 64.
    Schmidt HHHW, Lohmann WU. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1993; 1178: 153–75.PubMedGoogle Scholar
  65. 65.
    Hibbs JR Jr, Taintor RR, Vavrin Z et al. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In: Moncada S, Higgs EA, eds. Nitric Oxide from L-arginine: a Bio-regulatory System. Amsterdam: Elsevier, 1990: 189–224.Google Scholar
  66. 66.
    Lepoivre M, Fieschi F, Coves J et al. Inactivation of ribonucleotide reductase by nitric oxide. Biochem Biophys Res Commun 1991; 179: 442–8.PubMedGoogle Scholar
  67. 67.
    Wink DA, Kasprzak KS, Maragos CM et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 1001–3.PubMedGoogle Scholar
  68. 68.
    Stamler JS, Simon DI, Osborne JA et al. S-nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992; 89: 444–8.PubMedGoogle Scholar
  69. 69.
    Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide ion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454–6.PubMedGoogle Scholar
  70. 70.
    Beckman J, Tsai JH. Reactions and diffusion of nitric oxide and peroxynitrite. Biochemist 1994; 16: 8–10.Google Scholar
  71. 71.
    Marldund SL, Holme E, Hellner L. Superoxide dismutase in extracellular fluids. Clin Chim Acta 1982; 126: 41–51.Google Scholar
  72. 72.
    Sinet PM, Heikkila RE, Cohen G. Hydrogen peroxide production in rat brain in vivo. J Neurochem 1980; 34: 1421–1428.PubMedGoogle Scholar
  73. 73.
    Nakajima M, Kashiwagi K, Hayashi Y et al. Alpha-tocopherol supports survival and neurite extension of neurons cultured from various regions of fetal rat brain. Neurosci Lett 1991; 133: 49–52.PubMedGoogle Scholar
  74. 74.
    Raps SP, Lai JCK, Hertz L et al. Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res 1989; 493: 398–401.PubMedGoogle Scholar
  75. 75.
    Gutteridge JM. Antioxidant properties of the proteins ceruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis. Biochem Biophys Acta 1986; 869: 119–127.Google Scholar
  76. 76.
    Thorburne SK, Jurlink BHJ. Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 1996; 67: 1014–1022.PubMedGoogle Scholar
  77. 77.
    Makar TK, Nedergaard M, Preuss A et al. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J Neurochem 1994; 62: 45–53.PubMedGoogle Scholar
  78. 78.
    Sagara J, Miura K, Bannai S. Cystine uptake and glutathione level in fetal brain cells in primary culture and suspension. J Neurochem 1993; 61: 1667–1671.PubMedGoogle Scholar
  79. 79.
    Sagara J, Miura K, Bannai S. Maintenance of neuronal glutathione by glial cells. J Neurochem 1993; 61: 1672–1676.PubMedGoogle Scholar
  80. 80.
    Devesa A, O’Connor JE, Garcia C et al. Glutathione metabolism in primary astrocyte cultures: flow cytometric evidence of heterogeneous distribution of GSH content. Brain Res 1993; 618: 181–189.PubMedGoogle Scholar
  81. 81.
    Janssen YW, Van Houten B, Borm PJA et al. Biology of the disease: cell and tissue responses to oxidative damage. Lab Invest 1993; 69: 261–274.PubMedGoogle Scholar
  82. 82.
    Spitz DR, Dewey WC, Li GC. Hydrogen peroxide or heat shock induces resistance to hydrogen peroxide in Chinese hamster fibroblasts. J Cell Physiol 1987; 131: 364–373.PubMedGoogle Scholar
  83. 83.
    Damier P, Hirsch EC, Zhang Y et al. Glutathione peroxidase, glial cells and Parkinson’s disease. Neuroscience 1993; 52: 1–6.PubMedGoogle Scholar
  84. 84.
    Takizawa S, Matsushima K, Shinohara Y et al Immunohistochemical localization of glutathione peroxidase in infarcted human brain. J Neurol Sci 1994; 122: 66–73.PubMedGoogle Scholar
  85. 85.
    Muller DPR, Goss-Sampson MA. Neuro-chemical, neurophysiological and neuro-pathological studies in vitamin E deficiency. Crit Rev Neurobiol 1990; 5: 239–255.Google Scholar
  86. 86.
    Spector R, Eells J. Deoxynucleoside and vitamin transport into the central nervous system. Federation Proc 1984; 43: 196–200.Google Scholar
  87. 87.
    Tan DX, Chen LD, Poeggeler B et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine J 1993; 1: 57–60.Google Scholar
  88. 88.
    Pieri C, Marra M, Moroni F et al. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 55: 271–276.Google Scholar
  89. 89.
    Sinet PM, Ceballos-Picot I. Role of free radicals in Alzheimer’s disease and Down’s syndrome. In: L Packer, L Prilipko, Y Christen, eds. Free Radicals in the Brain: Aging, Neurological and Mental Disorders, Springer-Verlag, Berlin, Heidelberg, 1992: 91–98.Google Scholar
  90. 90.
    Marklund SL, Adolfsson R, Gottfries CG et al. Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type. J Neurol Sci 1985; 7: 319–325.Google Scholar
  91. 91.
    Ceballos I, Javoy-Agid F, Delacourte A et al. Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer’s disease brains. Free Rad Res Comms 1991; 1213: 571–580.Google Scholar
  92. 92.
    Delacourte A, Defossez A, Ceballos I et al. Preferential expression of copper-zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer’s disease. Neurosci Lett 1988; 92: 247–253.PubMedGoogle Scholar
  93. 93.
    Ceballos I, Lafon M, Javoy-Agid F et al. Superoxide dismutase and Parkinson’s disease. The Lancet 1990; 335: 1035–1036.Google Scholar
  94. 94.
    Zhang P, Damier P, Hirsch EC et al. Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon. Neurosci 1993; 55: 167–175.Google Scholar
  95. 95.
    Bergeron C, Muntasser S, Somerville MJ et al. Copper/zinc superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis motorneurons. Brain Res 1994; 659: 272–276.PubMedGoogle Scholar
  96. 96.
    Bergeron C, Petrunka C, Weyer L. Copper/zinc superoxide dismutase expression in the human central nervous system. Am J Pathol 1996; 148: 273–279.PubMedGoogle Scholar
  97. 97.
    Ceballos I, Javoy-Agid F, Hirsch EC et al. Localization of copper-zinc superoxide dismutase mRNA in human hippocampus by in situ hybridization. Neurosci Lett 1989; 105: 41–46.PubMedGoogle Scholar
  98. 98.
    Elroy-Stein O, Bernstein Y, Groner Y. Overproduction of human CuZn-superoxide dismutase in transfected cells; extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO J 1986; 5: 615–622.PubMedGoogle Scholar
  99. 99.
    Ceballos I, Delabar JM, Nicole A et al. Expression of transfected human CuZn superoxide dismutase gene in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity. Biochem Biophys Acta 1988; 949: 58–64.PubMedGoogle Scholar
  100. 100.
    Elroy-Stein O, Groner Y. Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn-superoxide dismutase. Implication for gene dosage effects in Down syndrome. Cell 1988; 52: 259–267.PubMedGoogle Scholar
  101. 101.
    Bahmanyar S, Higgins GA, Goldgaber D et al. Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer’s disease. Science 1987; 237: 77–80.PubMedGoogle Scholar
  102. 102.
    Goedert TM. Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer’s disease. EMBO J 1987; 6: 3627–3632.PubMedGoogle Scholar
  103. 103.
    Blanquet V, Goldgaber D, Turleau C et al. The (3 amyloid protein (AD-AP) cDNA hybridizes in normal and Alzheimer individuals near the interface of 21q21 and q22.1. Ann Genet 1987; 30: 68–69.PubMedGoogle Scholar
  104. 104.
    Wakai M, Mokuno K, Hashizume Y, Kato K. An immunohistochemical study of the neuronal expression of superoxide dismutase in sporadic amyotrophic lateral sclerosis. Acta Neuropathol 1994; 88: 151–158.PubMedGoogle Scholar
  105. 105.
    Ceballos-Picot I, Nicole A, Briand P et al. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effect in Down’s syndrome. Brain Res 1991; 552: 198–214.PubMedGoogle Scholar
  106. 106.
    Furuta A, Price DL, Pardo CA et al. Localization of superoxide dismutases in Alzheimer’s disease and Down’s syndrome neocortex and hippocampus. Am J Pathol 1995; 146: 357–367.PubMedGoogle Scholar
  107. 107.
    Somerville MJ, Percy ME, Bergeron C et al. Localization and quantitation of 68 kDa neurofilament and superoxide dismutase-1 mRNA in Alzheimer brains. Mol Brain Res 1991; 9: 1–8.PubMedGoogle Scholar
  108. 108.
    Pardo CA, Xu Z, Borchelt DR et al. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci 1995; 92: 954–958.PubMedGoogle Scholar
  109. 109.
    Tyrrel RM, Applegate LA, Tromvoukis Y. The proximal promotor region of the human heme oxygenase gene contains elements involved in stimulation of transcriptional activity by a variety of agents including oxidants. Carcinogenesis 1993; 14: 761–765.Google Scholar
  110. 110.
    Smith MA, Kutty RK, Richey PL et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer’s disease. Am J Pathol 1994; 145: 42–47.PubMedGoogle Scholar
  111. 111.
    Maines MD. Herne oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988; 2: 2557–2568.PubMedGoogle Scholar
  112. 112.
    Stocker R, Yamamoto Y, McDonagh AF et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043–1046.PubMedGoogle Scholar
  113. 113.
    Verma A, Hirsch DJ, Glatt CE et al. Carbon monoxide: a putative neural messenger. Science 1993; 259: 381–384.PubMedGoogle Scholar
  114. 114.
    Smith MA, Taneda S, Richey PL et al. Immunocytochemical demonstration of advanced Maillard reaction products in Alzheimer disease pathology. Proc Natl Acad Sci USA 1994; 91: 5710–5714.PubMedGoogle Scholar
  115. 115.
    Selkoe DJ, Ihara Y, Salazar FJ. Alzheimer’s disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science 1982; 215: 1243–1245.PubMedGoogle Scholar
  116. 116.
    Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993; 261: 921–923.Google Scholar
  117. 117.
    Strittmatter WJ, Weisgraber KH, Huang DY et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer’s disease. Proc Natl Acad Sci USA 1993; 90: 8098–8102.Google Scholar
  118. 118.
    Nakamura S, Kawamata T, Akiguchi I et al. Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropathol 1990; 80: 419–425.PubMedGoogle Scholar
  119. 119.
    Asoh KI, Watanabe Y, Mizoguchi H et al. Induction of manganese superoxide dismutase by tumor necrosis factor in human breast cancer MCF-7 cell line and its TNF-resistant variant. Biochem Biophys Res Commun 1989; 162: 794–801.PubMedGoogle Scholar
  120. 120.
    Ho YS, Howard AJ, Crapo JD. Molecular structure of a functional rat gene for manganese-containing superoxide dismutase. Am J Respir Cell Molec Biol 1991; 4: 278–286.Google Scholar
  121. 121.
    Liu X-H, Kato H, Araki T et al. An immunohistochemical observation of manganese superoxide dismutase in rat sub-stantia nigra after occlusion of middle cerebral artery. Neurosc Lett 1994; 173: 103–106.Google Scholar
  122. 122.
    Akai F, Maeda M, Suzuki K et al. Immunocytochemical localization of manganese superoxide dismutase (MnSOD) in the hippocampus of the rat. Neurosc Lett 1990; 115: 19–23.Google Scholar
  123. 123.
    Inagaki S, Takagi H, Suzuki K et al. Intense immunoreactivity for Mn-superoxide dismutase (MnSOD) in cholinergic and non-cholinergic neurons in the rat basal forebrain. Brain Res 1991; 541: 354–357.PubMedGoogle Scholar
  124. 124.
    Inagaki S, Suzuki K, Taniguchi N et al. Localization of Mn-superoxide dismutase (MnSOD) in cholinergic and somatostatin-containing neurons in the rat neo-striatum. Brain Res 1991; 549: 174–177.PubMedGoogle Scholar
  125. 125.
    Zhang P, Anglade P, Hirsch EC et al. Distribution of manganese-dependent superoxide dismutase in the human brain. Neuroscience 1994; 61: 317–330.PubMedGoogle Scholar
  126. 126.
    Ransmayr G, Cervera P, Hirsch E et al. Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer’s disease. Neuroscience 1989; 32: 701–714.PubMedGoogle Scholar
  127. 127.
    Pappolla MA, Omar RA, Kim KS et al. Immunohistochemical evidence of antioxidant stress in Alzheimer’s disease. Am J Pathol 1992; 140: 621–628.PubMedGoogle Scholar
  128. 128.
    Fleming JE, Miguel J, Cottrell SF et al. Is cell aging caused by respiration-dependent injury to the mitochondrial genome? Gerontology 1982; 28: 44–53.PubMedGoogle Scholar
  129. 129.
    Shapira AHV, Mann VM, Cooper JM et al. Anatomical and disease specificity of NADH CoQ1 reductase (Complex 1) deficiency in Parkinson’s disease. J Neurochem 1990; 55: 2142–2145.Google Scholar
  130. 130.
    Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992; 256: 628–632.PubMedGoogle Scholar
  131. 131.
    Norrgren G, Ebendal T, Belew M et al. Release of nerve growth factor by human glial cells in culture. Expl Cell Res 1980; 130: 31–39.Google Scholar
  132. 132.
    Mattson MP, Rychlik B, Chu C et al. Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28K in cultured hippocampal neurons. Neuron 1991; 6: 41–51.PubMedGoogle Scholar
  133. 133.
    Dexter DT, Wells FR, Lees A et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson’s disease. J Neurochem 1989; 52: 1830–1836.PubMedGoogle Scholar
  134. 134.
    Dringen R, Hamprecht B. Glutathione content as an indicator for the presence of metabolic pathways of amino acids in astroglial cultures. J Neurochem 1996; 67: 1375–1382.PubMedGoogle Scholar
  135. 135.
    Bolanos JP, Heales SJR, Land JM et al. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurons and astrocytes in primary cultures. J Neurochem 1995; 64: 1965–1972.PubMedGoogle Scholar
  136. 136.
    Han S-K, Mytilineou C, Cohen G. L-Dopa upregulates glutathione and protects mesencephalic cultures against oxidative stress. J Neurochem 1996; 66: 501–510.PubMedGoogle Scholar
  137. 137.
    Slivka A, Mytilineou C, Cohen G. Histochemical evaluation of glutathione in brain. Brain Res 1987; 409: 275–284.PubMedGoogle Scholar
  138. 138.
    Philbert MA, Beiswanger CM, Waters DK et al. Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and Ophtaldialdehyde-induced histofluorescence. Toxicol and Applied Pharmacol 1991; 107: 215–227.Google Scholar
  139. 139.
    Whittemore ER, Loo DT, Cotman CW. Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. NeuroReport 1994; 5: 1485–1488.PubMedGoogle Scholar
  140. 140.
    Desagher S, Glowinski J, Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J Neuroscience 1996; 16: 2553–2556.Google Scholar
  141. 141.
    Coyle JT, Puttfarken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689–69.PubMedGoogle Scholar
  142. 142.
    Hartley DM, Kurth MC, Bjerkness L et al. Glutamate receptor-induced 45Ca2* accumulation in cortical cell culture correlates with subsequent neuronal degeneration. J Neurosci 1993; 13: 1993–2000.PubMedGoogle Scholar
  143. 143.
    Tymianski M, Wallace MC, Spigelman I et al. Cell-permeant Ca’ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron 1993; 11: 221–35.PubMedGoogle Scholar
  144. 144.
    Tymianski M, Charlton MP, Carlen PL et al. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci 1993; 13: 2085–2104.PubMedGoogle Scholar
  145. 145.
    Mattson MP, Lovell MA, Furukawa K et al. Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca“ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 1995; 65: 1740–1751.PubMedGoogle Scholar
  146. 146.
    Dykens JA. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca’ and Nat: implications for neurodegeneration. J Neurochem 1994; 63: 584–91.PubMedGoogle Scholar
  147. 147.
    Monyer H, Hartley DM, Choi DW. 21aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures. Neuron 1990; 5: 121–126.PubMedGoogle Scholar
  148. 148.
    Chan PH, Chu L, Chen SF et al. Reduced neurotoxicity in transgenic mice over-expressing human copper-zinc-superoxide dismutase. Stroke 1990; 21: 11180–11182.Google Scholar
  149. 149.
    Verity MA. Mechanisms of phospholipases A2 activation and neuronal injury. Ann NY Acad Sci 1993; 679: 110–120.PubMedGoogle Scholar
  150. 150.
    Mattson MP, Barger SW, Begley JG et al. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol 1995; 46: 187–216.PubMedGoogle Scholar
  151. 151.
    Dugan LL, Sensi SL, Canzoniero LMT et al. Imaging of mitochondrial oxygen radical production in cortical neurons exposed to NMDA. Soc Neurosci Abstr 1994; 20: 1532 (Abstract).Google Scholar
  152. 152.
    Beckman JS. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 1991; 15: 53–59.PubMedGoogle Scholar
  153. 153.
    Beckman JS, Crow JP. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 1993; 21: 330–334.PubMedGoogle Scholar
  154. 154.
    Williams JH, Errington ML, Lynch MA et al. Arachidonic acid induces a longterm activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 1989; 341: 739–742.PubMedGoogle Scholar
  155. 155.
    Gaily JA, Montague PR, Reeke GN Jr et al. The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Natl Acad Sci USA 1990; 87: 3547–3551.Google Scholar
  156. 156.
    Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci 1991; 14: 75–82.Google Scholar
  157. 157.
    Farinelli SE, Park DS, Greene LA. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J Neurosci 1996; 16: 2325–2334.PubMedGoogle Scholar
  158. 158.
    De Jong AMP, Albracht SPJ. Ubisemiquinones as obligatory intermediates in the electron transfer from NADH to ubiquinone. Eur J Biochem 1994; 222: 975–82.PubMedGoogle Scholar
  159. 159.
    Patole MS, Swaroop A, Ramasarma T. Generation of H202 in brain mitochondria. J Neurochem 1986; 47: 1–8.PubMedGoogle Scholar
  160. 160.
    Beal MF. Aging, energy and oxidative stress in neurodegenerative diseases. Ann Neurol 1995; 38: 357–66.PubMedGoogle Scholar
  161. 161.
    Werth JL, Thayer SA. Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J Neurosci 1994; 14: 348–56.PubMedGoogle Scholar
  162. 162.
    Novelli A, Reilly JA, Lysko PG et al. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988; 451: 205–12.PubMedGoogle Scholar
  163. 163.
    Polla BS, Kantengwa S, Francois D et al. Mitochondria are selective targets for the protective effects of heat shock against oxidative injury Proc Natl Acad Sci USA 1996; 93: 6458–6463.Google Scholar
  164. 164.
    Pacifici RE, Doviesk JA. Protein, lipid and free-radical theory of aging revisited. Gerontology 1991; 37: 166–180.PubMedGoogle Scholar
  165. 165.
    Stadtman ER. Oxidation of proteins by mixed-function oxidation system: Implication in protein turnover, ageing and neutrophil function. Trends Biochem Sci 1986; 11: 11–12.Google Scholar
  166. 166.
    Teebor GW, Boorstein RJ, Cadet J. The repairability of oxidative free radical mediated damaged to DNA: a review. I’1t J Radiat Biol 1988; 54: 131–150.Google Scholar
  167. 167.
    Thomas JP, Maiorino M, Ursini F et al. Protective action of phospholipid hydro-peroxide glutathione peroxidase against membrane-damaging lipid peroxidation. J Biol Chem 1990; 265: 454–461.PubMedGoogle Scholar
  168. 168.
    Niki E, Noguchi N, Gotoh N. Dynamics of lipid peroxidation and its inhibition by antioxidants. Biochem Soc Trans 1993; 21: 313–317.PubMedGoogle Scholar
  169. 169.
    Stadtman ER. Protein oxidation and aging. Science 1992; 257: 1220–1224.PubMedGoogle Scholar
  170. 170.
    Smith CD, Carney JM, Starke-Reed PE et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 1991; 88: 10540–10543.PubMedGoogle Scholar
  171. 171.
    Yan SD, Schmidt AM, Anderson GM et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding protein. Proc Natl Acad Sci USA 1994; 91: 7787–7791.PubMedGoogle Scholar
  172. 172.
    Smith MA, Sayre LM, Monnier VM et al. Radical AGEing in Alzheimer’s disease. Treds Neurosci 1995; 18: 172–176.Google Scholar
  173. 173.
    Wang J-Z, Grundke-Igbal I, Iqbal K. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer’s disease. Nature Med 1996; 2: 871–875.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • Irène Ceballos-Picot
    • 1
  1. 1.Hôpital NeckerParisFrance

Personalised recommendations